[ 1 ] Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association[J]. Circulation, 2017, 135(10):e146-e603.
[ 2 ] Burns RJ, Gibbons RJ, Yi Q, et al. The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis[J]. J Am Coll Cardiol, 2002, 39(1):30-36.
[ 3 ] Kelle S, Roes SD, Klein C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging[J]. J Am Coll Cardiol, 2009, 54(19):1770-1777.
[ 4 ] Velagaleti RS, Pencina MJ, Murabito JM, et al. Long-term trends in the incidence of heart failure after myocardial infarction[J]. Circulation, 2008, 118(20):2057-2062.
[ 5 ] Wollert KC, Drexler H. Cell therapy for the treatment of coronary heart disease: a critical appraisal[J]. Nat Rev Cardiol, 2010, 7(4):204-215.
[ 6 ] Korf-Klingebiel M, Reboll MR, Klede S, et al. Myeloid-derived growth factor(C19orf10)mediates cardiac repair following myocardial infarction[J]. Nat Med, 2015, 21(2):140-149.
[ 7 ] Grimmond SM, Miranda KC, Yuan Z, et al. The mouse secretome: functional classification of the proteins secreted into the extracellular environment[J]. Genome Research, 2003, 13(6B):1350-1359.
[ 8 ] Jay SM, Lee RT. Protein engineering for cardiovascular therapeutics: untapped potential for cardiac repair [J]. Circ Res, 2013, 113(7):933-943.
[ 9 ] Senniappan S, Brown RE, Hussain K. Genomic and morphoproteomic correlates implicate the IGF-1/mTOR/AKT pathway in the pathogenesis of diffuse congenital hyperinsulinism[J]. Int J Clin Exp Pathol, 2016, 9(2):548-562.
[10] Yu J, Li M, Qu Z, et al. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/AKT[J]. J Cardiovasc Pharmacol, 2010, 55(5):496-505.
[11] Arslan F, Lai RC, Smeets MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/AKT pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury[J]. Stem Cell Res, 2013, 10(3):301-312.